Home/Filings/4/0001209191-22-001710
4//SEC Filing

Lui Alfred Fu Kong 4

Accession 0001209191-22-001710

CIK 0000822370other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:33 PM ET

Size

6.0 KB

Accession

0001209191-22-001710

Insider Transaction Report

Form 4
Period: 2022-01-03
Transactions
  • Purchase

    Common stock, $0.001 par value

    2022-01-03$1.58/sh+10,000$15,80010,000 total
Holdings
  • Common stock, $0.001 par value

    (indirect: By Trust)
    32,358
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.65, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

Issuer

Emmaus Life Sciences, Inc.

CIK 0000822370

Entity typeother

Related Parties

1
  • filerCIK 0001877239

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:33 PM ET
Size
6.0 KB